Circulating IL-6 but not neutrophil extracellular traps levels can predict anakinra effectiveness in patients with severe COVID-19.


Journal

Journal of leukocyte biology
ISSN: 1938-3673
Titre abrégé: J Leukoc Biol
Pays: England
ID NLM: 8405628

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 16 6 2022
medline: 30 11 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

Added data on circulating IL-6 levels can predict COVID-19 severity and IL1RA efficiency.

Identifiants

pubmed: 35704508
doi: 10.1002/JLB.4LT0122-018RR
pmc: PMC9349441
doi:

Substances chimiques

Interleukin 1 Receptor Antagonist Protein 0
Interleukin-6 0

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1365-1367

Commentaires et corrections

Type : CommentOn

Informations de copyright

©2022 Society for Leukocyte Biology.

Auteurs

Vanessa Granger (V)

Immunology Department, Bichat Hospital, APHP, DMU BIOGéM, Paris, France.
Inserm, Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Châtenay-Malabry, France.

Audrey Fels (A)

Clinical Research Department, Paris-Saint Joseph Hospital Group, Paris, France.

Thomas Huet (T)

Rheumatology Department, Paris-Saint Joseph Hospital Group, Paris, France.

Jean-Louis Laplanche (JL)

Biochemistry & Molecular Biology Department, Saint-Louis Lariboisière and Fernand-Widal Hospital Group, Paris, France.

Sophie Laplanche (S)

Biology Department, Paris-Saint Joseph Hospital Group, Paris, France.

Gilles Chatellier (G)

Clinical Research Department, Paris-Saint Joseph Hospital Group, Paris, France.

Hélène Beaussier (H)

Clinical Research Department, Paris-Saint Joseph Hospital Group, Paris, France.

Sylvie Chollet-Martin (S)

Immunology Department, Bichat Hospital, APHP, DMU BIOGéM, Paris, France.
Inserm, Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Châtenay-Malabry, France.

Luc de Chaisemartin (L)

Immunology Department, Bichat Hospital, APHP, DMU BIOGéM, Paris, France.
Inserm, Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Châtenay-Malabry, France.

Gilles Hayem (G)

Rheumatology Department, Paris-Saint Joseph Hospital Group, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH